Pfizer Completes Acquisition Of Wyeth
16 October 2009 - 3:46AM
Dow Jones News
Pfizer Inc. (PFE) said Thursday it completed its $68 billion
acquisition of Wyeth (WYE) after having received final regulatory
approvals on Wednesday.
Under the acquisition agreement, each outstanding share of Wyeth
common stock has been converted into the right to receive $33 in
cash without interest and 0.985 of a share of Pfizer common
stock.
Wyeth shares will stop trading after the closing bell today.
They were recently up 4 cents to $50.08. Pfizer shares were up 2
cents to $17.39
-By Wallace Witkowski, 415-439-6400;
AskNewswires@dowjones.com